EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
13.47
-0.13 (-0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
13.45
-0.02 (-0.15%)
After-hours: Apr 28, 2026, 6:14 PM EDT
EyePoint Employees
EyePoint had 214 employees as of December 31, 2025. The number of employees increased by 49 or 29.70% compared to the previous year.
Employees
214
Change (1Y)
49
Growth (1Y)
29.70%
Revenue / Employee
$146,593
Profits / Employee
-$1,083,935
Market Cap
1.12B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| UroGen Pharma | 291 |
| uniQure | 221 |
| Omeros | 175 |
| Zenas BioPharma | 167 |
| Septerna | 130 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
EYPT News
- 12 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - EyePoint Transcript: RBC Capital Markets Virtual Ophthalmology Conference - Transcripts
- 5 weeks ago - EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug - Reuters
- 7 weeks ago - EyePoint Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 2 months ago - EyePoint Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema - GlobeNewsWire
- 2 months ago - EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire